Effect of Peer-led Educational Intervention on Treatment Outcomes Among Adults With Drug-susceptible Pulmonary Tuberculosis in South Omo and Ari Zone, Southern Ethiopia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBahirdar University

About this trial

The study might come up with valuable findings to address poor treatment outcome, poor quality of life, disability score and depressive symptoms. The findings may also be decreased health professional workload. The findings would be supportive evidences for policy makers, program managers, to clinician as well as the patients themselves and for other researchers. The study may help to promote and maintain good treatment outcome for the patients in the study area as well as the country. The findings will also be used for teaching \& learning purposes in educational \& training programs.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults with new drug-susceptible pulmonary TB who will be diagnosed in bacteriological diagnostic methods

not participating in similar study,

mentally capable to provide consent,

physically capable of following the intervention.

Disqualifiers

Seriously ill patients at the time of screening or enrollment

Tuberculosis patients with a known plan to be transferred out of the study sites

Trial design

Design model

Single group

Treatments tested in this trial

  • peer-led education

    Combination product

    The Intervention is a structured, evidence-based program designed to promote positive and sustained behavioral changes among participants through education, counseling, and supportive follow-up

Treatment groups

250 Participants
are divided into 1 treatment group
Group A: Peer-Led Educational Intervention plus Standard TB TreatmentActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

treatment success rate

as defined by 7th edition of Ethiopian guidelines for clinical and programmatic management of TB, TB/HIV, DR-TB and Leprosy and by WHO. Data on the patients' status on the primary outcome variable will be extracted from TB register logbook.

Time frame
the primary outcome will be measured at the end of 6 months i.e after July 24/2026

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.